RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...
This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...
We look forward to that as it’ll be a big help to anyone trying to hack diabetes care. Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.